Hibiwash® 4% w/v Cutaneous Solution
Hibiscrub® is changing to Hibiwash®
Hibiwash® is an antimicrobial full body wash with 4% Chlorhexidine Gluconate and emollients, designed to keep patients' skin protected from a wide range of microorganisms while being gentle on the skin.
✚ Clear, Fragrance-Free, Soya Oil-Free
✚ Various Sizes Available
✚ Sold Individually
Indications
✚ An antiseptic for pre-operative and post-operative disinfection of the hands and skin.
Main Ingredients
✚ Chlorhexidine Digluconate (as 20% solution -4% w/v), Propan-2-ol (Isopropyl Alcohol)
Characteristics
✚ A clear, colourless, viscous liquid, with no fragrance and no soya oil. Contains emollients.
Hibiwash® is your trusted partner in helping prevent infections, promote skin's integrity and save time before performing surgical procedures. It contains 4% Chlorhexidine Gluconate for a wide range of antimicrobial activity [1], [2] and has been used for many decades in hospitals.
Regular use of Hibiwash® can help reduce the chance of 11 in 100 patients contracting an SSI up to 30 days after surgery. [3]
Hibiwash® is not absorbed into the skin, but binds to it to form a protective layer that removes and kills microorganisms and continues to do so for a long period of time after application. [5], [6], [7] Unlike Povidone Iodine, Hibiwash® is not inactivated by bodily fluids. [8]
Hibiwash® has been reformulated to be a more sustainable product, using fewer raw materials and less energy in its production. The removal of colour, fragrance and traces of soya oil makes it less likely to cause irritation or an allergic reaction and has the potential of an increased compliance. It also contains emollients and is gentle on the skin, even with frequent use.
References:
[1] Mölnlycke Health Care, [2] SmPC for HibiWash UK, [3] Gillespie B.M. 2021. Worldwide incidence of surgical site infections in general surgical patients: A systematic review and meta-analysis of 488,594 patients. International Journal of Surgery, 95, p.106136, [5] Mölnlycke Health Care. Internal Report REPR0495. Data on file, [6] Case DE., Chlorhexidine: Attempt to detect percutaneous absorption in man, Proceedings of the 9th International Congress of Chemotherapy, J.D. Williams & A.M. Geddes ED., 1976;3 (Chemotherapy): 367-374, [7] Tanner J et al. A fresh look at perioperative body washing. Journal of Infection Prevention. 2012; (13) 11 - 15, [8] Sheikh W. Comparative Antibacterial Efficacy of HiBiClens® and Betadine® in the Presence of Pus Derived from Human Wounds. Current Therapeutic Research 1986;40:6: 1096-1102.
